Nazata Bio is a healthcare startup focused on developing digital therapeutics aimed at managing high blood pressure, a leading risk factor for all-cause mortality worldwide. The company's flagship product, the HeartShield app, empowers patients to reduce their blood pressure through personalized guidance. The app utilizes a personalization algorithm to tailor treatment to each patient's unique needs, ensuring optimal outcomes. Patients receive support from a team of specialists, including dietitians, exercise coaches, and behavioral scientists, facilitating comprehensive management of their condition. This innovative approach aims to achieve the greatest reduction in blood pressure, which is crucial in preventing serious health events such as heart attacks, strokes, and heart failure.